Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

The renewal of the National Cervical Screening Program

Carter, J. R. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00820 · Cited by 13

HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns

Bosch, F. X., & Robles, C. (2018) · Salud Pública de México · doi:10.21149/10171 · Cited by 13

Evolving HPV diagnostics: current practice and future frontiers

Shi, L., Chen, H., Zhang, Z., Wang, Y., Ren, W., & Huang, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1681779 · Cited by 13

Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot

Rebolj, M., Mathews, C. S., Denton, K. J., & for the HPV Pilot Steering Group (2022) · Cancer Cytopathology · doi:10.1002/cncy.22572 · Cited by 12

Prevalence of Human Papillomavirus (HPV) Genotypes among Women During 2015–2020 in Mashhad, Iran

Bakhshani, A., Ganjali, R., & Tabatabaeizadeh, S. (2023) · Archives of Iranian Medicine · doi:10.34172/aim.2023.64 · Cited by 12

Triage performance of DNA methylation for women with high-risk human papillomavirus infection

Kong, L., Xiao, X., Wu, H., You, Y., Jin, X., Liou, Y., Liu, P., Lang, J., & Li, L. (2024) · The Oncologist · doi:10.1093/oncolo/oyae324 · Cited by 12

Challenges and Opportunities for Global Cervical Cancer Elimination: How Can We Build a Model for Other Cancers?

Adebamowo, C., Rossi, P. G., & Castle, P. E. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-473702 · Cited by 13

Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening Model

Austin, R. M., & Oniśko, A. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.05.001 · Cited by 12

The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital

Choi, J., Kim, Y., Lee, J.-H., & Kim, Y. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21632 · Cited by 12

Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?

Domgue, J. F., SCHIFFMAN, M. H., Wentzensen, N., Gage, J. C., Castle, P. E., Raine‐Bennett, T. R., Fetterman, B. J., Lorey, T. S., Poitras, N. E., Befano, B., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00492-17 · Cited by 13

A cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening

Wang, H.-R., Li, Y., Guo, H., Yu, L., Wu, Z., Yin, J., Liao, G., Qu, Y., Jiang, Y., Wang, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19870 · Cited by 12

Cervical screening in HPV-vaccinated populations

Canfell, K. (2018) · Climacteric · doi:10.1080/13697137.2018.1428296 · Cited by 12

Comparison between professional sampling and self‐sampling for HPV ‐based cervical cancer screening among postmenopausal women

Bergengren, L., Kaliff, M., Larsson, G. L., Karlsson, M. G., & Helenius, G. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12538 · Cited by 12

Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand

Smith, M. A., Hall, M. T., Lew, J., & Canfell, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.063 · Cited by 12

A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer

Wang, L., Du, W., Zhu, S., Jiang, P., & Zhang, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09655-9 · Cited by 12

Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV‐negative cervical cancer

Arsdale, A. V., Patterson, N. E., Maggi, E. C., Agoni, L., Doorslaer, K. V., Harmon, B. E., Nevadunsky, N. S., Kuo, D. Y.-S., Einstein, M. H., Lenz, J., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22799 · Cited by 13

Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis

Fan, Z., Feng, X., Zhang, W., Zhang, X., & Lin, J. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.04.003 · Cited by 12

Performance and acceptability of self-collected human papillomavirus testing among women living with HIV

Wang, R., Lee, K., Gaydos, C. A., Anderson, J., Keller, J., & Coleman, J. S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.047 · Cited by 13

Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study

Bertucci, M., Bonnet, E., Satger, L., Kreiche, A., Chappert, J.-L., Loy-Morel, S., Segondy, M., Daurès, J. P., & Boulle, N. (2020) · Women & Health · doi:10.1080/03630242.2020.1831683 · Cited by 12

Women’s knowledge and attitudes towards cervical cancer prevention: A qualitative study in the Spanish context

Borrull‐Guardeño, J., Sebastiá‐Laguarda, C., Colomer, F. D., & Sánchez‐Martínez, V. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15687 · Cited by 12

Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program

Hortlund, M., Mühr, L. S. A., Lagheden, C., Hjerpe, A., & Dillner, J. (2021) · International Journal of Cancer · doi:10.1002/ijc.33769 · Cited by 12

Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study

Hanley, S. J. B., Fujita, H., Aoyama‐Kikawa, S., Kasamo, M., Torigoe, T., Matsuno, Y., Sakuragi, N., & for the COMPACT study group (2021) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2021.32.e86 · Cited by 12

Direct bisulphite conversion of cervical samples for DNA methylation analysis

Verhoef, L., Floore, A. N., Doorn, S., Cuschieri, K. S., Bhatia, R., Hesselink, A. T., Meijer, C. J. L. M., Steenbergen, R. D. M., & Heideman, D. A. M. (2021) · Epigenetics · doi:10.1080/15592294.2021.1992911 · Cited by 12

Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings

Asgary, R. G., Beideck, E., & Naderi, R. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106883 · Cited by 12

Circular RNA circYPEL2: A Novel Biomarker in Cervical Cancer

Zhang, X., Yang, S., Chen, W., Dong, X., Zhang, R., Ye, H., Mei, X., Liu, H., Yu, F., & He, C. (2021) · Genes · doi:10.3390/genes13010038 · Cited by 12

The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe

Carcopino, X., Cruickshank, M. E., Leeson, S. C., Redman, C. W. E., & Nieminen, P. (2022) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000677 · Cited by 12

Eradication of cervical cancer in Latin America

Bosch, F. X. (2016) · Salud Pública de México · doi:10.21149/spm.v58i2.7777 · Cited by 12

“So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study

Zammit, C. M., Creagh, N. S., McDermott, T. L., Smith, M. A., Machalek, D. A., Jennett, C. J., Prang, K.-H., Sultana, F., Nightingale, C. E., Rankin, N. M., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315776 · Cited by 13

‘I’m a bit of a champion for it actually’: qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia

Zammit, C. M., Creagh, N. S., Nightingale, C. E., McDermott, T. L., Saville, M., Brotherton, J. M. L., & Kelaher, M. (2023) · Primary Health Care Research & Development · doi:10.1017/s1463423623000191 · Cited by 12

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study

Gottschlich, A., Gondara, L., Smith, L., Anderson, J. J., Cook, D. A., Krajden, M., Lee, M. H., Martin, R. E., Melnikow, J. A., Peacock, S. J., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100598 · Cited by 12

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology

Mazurec, K., Trzeszcz, M., Mazurec, M., Streb, J., Hałoń, A., & Jach, R. (2023) · Cancers · doi:10.3390/cancers15205095 · Cited by 12

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results

Zhang, Y., Zhang, W., Du, H., Qu, X., Chen, Y., Wang, J., & Wu, R. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08737-4 · Cited by 13

Incarcerated women's HPV awareness, beliefs, and experiences

Pankey, T. L., & Ramaswamy, M. (2015) · International Journal of Prisoner Health · doi:10.1108/ijph-05-2014-0012 · Cited by 12

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media

Luo, H., Du, H., Maurer, K. A., Belinson, J. L., Wang, G., Liu, Z., Zhang, L., Zhou, Y., Wang, C., Tang, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148168 · Cited by 12

Primary HPV testing verification: A retrospective ad‐hoc analysis of screening algorithms on women doubly tested for cytology and HPV

Tracht, J. M., Wrenn, A., & Eltoum, I.-E. A. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23726 · Cited by 12

Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples

Stevenson, A., Kavanagh, K., Pan, J., Stevenson, L. W., Griffin, H. M., Doorbar, J., Scott, E., Deeny, M., Cuschieri, K. S., & Graham, S. V. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.08.011 · Cited by 12

HIGH‐RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?

Kares, S., Veijalainen, O., Kholová, I., Tirkkonen, M., Vuento, R., Huhtala, H., Tuimala, V., Mäenpää, J., & Kujala, P. M. (2019) · Apmis · doi:10.1111/apm.12990 · Cited by 12

Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method

McLarty, J. W., Williams, D. L., Loyd, S., & Hagensee, M. E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001045 · Cited by 12

Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study

Riibe, M. Ø., Sørbye, S. W., Simonsen, G. S., Sundsfjord, A., Ekgren, J., & Maltau, J. M. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00386-z · Cited by 12

Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions

Liu, Y., Liao, J., Yi, X., Pan, Z., Pan, J., Sun, C., Zhou, H., & Meng, Y. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06415-5 · Cited by 12

Effect of Condom Use after CIN Treatment on Cervical HPV Biomarkers Positivity: Prolonged Follow Up Study

Valasoulis, G., Michail, G., Pouliakis, A., Georgios, A., Panayiotides, I. G., Kyrgiou, M., Daponte, A. I., & Paraskevaidis, E. A. (2022) · Cancers · doi:10.3390/cancers14143530 · Cited by 12

High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology

Musa, J., Achenbach, C. J., Taiwo, B., Berzins, B., Silas, O. A., Daru, P. H., Agbaji, O. O., Imade, G., Sagay, A. S., Idoko, J. A., et al. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-36 · Cited by 12

Infecção por HPV em mulheres atendidas pela Estratégia Saúde da Família

Ayres, A. R. G., Silva, G. A. E., Bustamante-Teixeira, M. T., Duque, K. D. C. D., Machado, M. L. S. M., Gamarra, C. J., & Levi, J. E. (2017) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2017051000065 · Cited by 12

Cervical human papillomavirus among 19 753 women attending gynecological department of a major comprehensive hospital in north Anhui China 2013‐2016: Implication for cervical cancer screening and prevention

Liu, H., Wei, X., Xie, Z., Wang, X., Gong, X., Ke, W., & Zou, H. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25365 · Cited by 12

The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications

Hall, M. T., Smith, M. A., Lew, J., O’Hallahan, J., Fentiman, G., Neal, H., Sage, M., & Canfell, K. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.045 · Cited by 12

Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening

Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.05.041 · Cited by 12

HPV-based screening for prevention of invasive cervical cancer – Authors' reply

Ronco, G., Meijer, C. J. L. M., Segnan, N., Kitchener, H. C., Rossi, P. G., Peto, J., & Dillner, J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60645-0 · Cited by 12

Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology

Gori, S., Venturelli, F., Carozzi, F. M., Rossi, P. G., Mistro, A. D., on behalf of the Multisocietal Contributor Group, Maggino, T., Giornelli, R., Cristoforoni, P. M., Negri, G., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03161-8 · Cited by 11

CIN2 in the Era of Risk-Based Management and HPV Vaccination: Epidemiology, Natural History and Guidelines

Bruno, M. T., Pagana, A., Giudice, C. L., Panella, M. M., Mascellino, G., & Laganà, A. S. (2025) · Diagnostics · doi:10.3390/diagnostics15192512 · Cited by 11

Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications

Pedersen, K., Silvestre, J. D., Sy, S., Portnoy, A., Castle, P. E., Kim, J. J., & Burger, E. A. (2026) · Annals of Internal Medicine · doi:10.7326/annals-25-03192 · Cited by 11

Cervical cancer mortality in Norway according to screening attendance and age

Baasland, I., Vie, G. Å., Romundstad, P., & Lönnberg, S. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14402 · Cited by 11

HnRNP K regulates inflammatory gene expression by mediating splicing pattern of transcriptional factors

Liu, S., Duan, Y., You, R., Chen, D., & Tan, J. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221110649 · Cited by 11

Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia

Kaoma, M., Olayemi, O., Mwaba, M. H., & Sikwewa, K. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02212-7 · Cited by 11

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study

Brotherton, J. M. L., McDermott, T. L., Smith, M. A., Machalek, D. A., Shilling, H. S., Prang, K.-H., Jennett, C. J., Nightingale, C. E., Zammit, C. M., Pagotto, A., et al. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102213 · Cited by 11

Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management

Bowden, S. J., Ellis, L. B., Kalliala, I. E. J., Paraskevaidi, M., Tighe, J., Kechagias, K. S., Doulgeraki, T., Paraskevaidis, E. A., Arbyn, M., Flanagan, J. M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071534 · Cited by 11

HPV Testing and its Role in Cervical Cancer Screening

Clarke, M. A. (2023) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000793 · Cited by 11

Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study

Dai, W., Wang, T. A., Chen, L., Qiu, Z., Chen, P., & Chen, D. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03258-x · Cited by 11

Human papillomavirus genotype and cycle threshold value from self-samples and risk of high-grade cervical lesions: A post hoc analysis of a modified stepped-wedge implementation feasibility trial

Lei, J., Cuschieri, K. S., Patel, H., Lawrence, A. C., Deats, K., YouScreen trial team, Sasieni, P. D., & Lim, A. W. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004494 · Cited by 11

Clinical and Analytical Evaluation of the Abbott Alinity m HR HPV Assay in a New Generation First‐Void Urine Collector

Keer, S. V., Téblick, L., Donders, G. G. G., Weyers, S., Doyen, J., Cornelis, A., de Vijver, K. K. V., Delbecque, K., Smet, A. D., Damme, P. V., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70254 · Cited by 11

Human Papillomavirus Testing for Primary Cervical Cancer Screening

Feldman, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4021 · Cited by 11

Five‐year risk of CIN 3 after short‐term HPV ‐ DNA negativity in cytology‐negative women: a population‐based cohort study

Mistro, A. D., Rossi, P. G., Frayle, H., Pasquale, L., Campari, C., Ronco, G., & Zorzi, M. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15893 · Cited by 11

Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia

Kussaibi, H., Dossary, R. A. A., Ahmed, A. M., Muammar, A., & Aljohani, R. (2020) · Acta Cytologica · doi:10.1159/000509669 · Cited by 11

The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics

Gage, J. C., Raine-Bennett, T., Schiffman, M., Clarke, M. A., Cheung, L. C., Poitras, N. E., Varnado, N. E., Katki, H. A., Castle, P. E., Befano, B., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0865 · Cited by 11

Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study

Rebolj, M., Mathews, C. S., Pesola, F., Castañón, A., Kitchener, H. C., & HPV Pilot Steering Group (2021) · International Journal of Cancer · doi:10.1002/ijc.33900 · Cited by 11

Clinical Performance of Triage Strategies for Hr-HPV–Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping

Stanczuk, G., Currie, H., Forson, W., Baxter, G., Lawrence, J., Wilson, A., Palmer, T., Arbyn, M., & Cuschieri, K. S. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-1425 · Cited by 11

Divergent effects of switching from cytology to HPV-based screening in the Nordic countries

Partanen, V., Dillner, J., Tropé, A., Ágústsson, Á. I., Lönnberg, S., Heinävaara, S. H., & Anttila, A. (2024) · European Journal of Public Health · doi:10.1093/eurpub/ckad225 · Cited by 11

Optimal Screening and Detection Strategies for Cervical Lesions: A Retrospective Study

Yang, Y., Xu, L., Yuan, S., Jin, L., Chen, P., & Wang, W. (2024) · Journal of Cancer · doi:10.7150/jca.96128 · Cited by 11

HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs

Campari, C., Fedato, C., Petrelli, A., Zorzi, M., Cogo, C., Caprioglio, A., Gallo, F., Giordano, L., Domenighini, S., Pasquale, L., et al. (2015) · Infectious Agents and Cancer · doi:10.1186/s13027-015-0009-x · Cited by 11

Detection of High-Risk Human Papillomaviruses in the Prevention of Cervical Cancer in India

Baskaran, K., Kumar, P. K., Santha, K., Sethupathy, S., Thamaraiselvi, B., & Swaruparani, S. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8187 · Cited by 11

Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization

Ravaioli, S., Tumedei, M. M., Amadori, A., Puccetti, M., Chiadini, E., & Bravaccini, S. (2016) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000261 · Cited by 11

Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18‐Year follow‐up of the Guanacaste cohort

Rodríguez, A. C., Ávila, C., Herrero, R., Hildesheim, A., Sherman, M. E., Burk, R. D., Morales, J., Alfaro, M., Guillén, D., Trejos, M. E., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30614 · Cited by 12

Vaginal Self-Sampling as a Diagnosis Tool in Low-Income Countries and Potential Applications for Exploring the Infectious Causes of Miscarriage

Lagier, J., Diagne, N., Fenollar, F., Tamalet, C., Sokhna, C., & Raoult, D. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0179 · Cited by 12

A new era for cervical screening in Australia: Watch this space!

Hammond, I. G., Canfell, K., & Saville, M. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12669 · Cited by 11

Value of Diffusion-Weighted Magnetic Resonance Imaging Combined with miR-18a Level in Predicting Radiosensitivity of Cervical Cancer

Bu, X., Zhang, J., Tian, F., Wang, X., Linyun, W., & Tian, W. (2018) · Medical Science Monitor · doi:10.12659/msm.910990 · Cited by 11

Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age

Ernstson, A., Asciutto, K. C., STURESSON, J., Norén, J., Forslund, O., & Borgfeldt, C. (2018) · Anticancer Research · doi:10.21873/anticanres.13123 · Cited by 11

Cervical Cancer Screening in Low-Resource Settings

Nessa, A., Anwar, B. R., & Begum, S. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_14 · Cited by 11

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

Kong, T., Kim, M., Kim, Y. H., Kim, Y. B., Kim, J., Kim, J., Park, M. H., Park, J. H., Rhee, J. H., Lim, M. C., et al. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2020.31.e31 · Cited by 12

Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry

Castle, P. E., Kinney, W., Chen, L., Kim, J. J., Jenison, S. A., Rossi, G., Kang, H., Cuzick, J. M., Wheeler, C. M., Joste, N. E., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab173 · Cited by 12

Sexually Transmitted Infections

(2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6637 · Cited by 11

Cost and Resource Utilization in Cervical Cancer Management: A Real-World Retrospective Cost Analysis

Cromwell, I., Ferreira, Z., Smith, L., van der Hoek, K., Ogilvie, G. S., Coldman, A. J., & Peacock, S. J. (2016) · Current Oncology · doi:10.3747/co.23.2914 · Cited by 11

Using the Cancer Risk Management Model to Evaluate the Health and Economic Impacts of Cytology Compared with Human Papillomavirus DNA Testing for Primary Cervical Cancer Screening in Canada

Popadiuk, C. M., Gauvreau, C. L., Bhavsar, M., Nadeau, C., Asakawa, K., Flanagan, W. M., Wolfson, M. C., Coldman, A. J., Memon, S., Fitzgerald, N. R., et al. (2016) · Current Oncology · doi:10.3747/co.23.2991 · Cited by 11

Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening

Rebolj, M., Njor, S. H., Lynge, E., Preisler, S., Ejegod, D. M., Rygaard, C., & Bonde, J. H. (2017) · Cytopathology · doi:10.1111/cyt.12451 · Cited by 11

HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia

Lie, A. K., Tropé, A., Skare, G. B., Bjørge, T., Jonassen, C. M., Brusegard, K., & Lönnberg, S. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.10.031 · Cited by 11

HPV screening for cervical cancer is reaching maturity

Canfell, K., Smith, M. A., Saville, M., & Arbyn, M. (2022) · BMJ · doi:10.1136/bmj.o1303 · Cited by 11

Options for triage and implications for colposcopists within European HPV-based cervical screening programmes

Leeson, S. C., Alalade, R., Singh, N., Nieminen, P., Cruickshank, M. E., Carcopino, X., & Bergeron, C. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.12.061 · Cited by 10

Experiences of human papillomavirus self‐sampling by women >60 years old: A qualitative study

Blomberg, K., & Nyman, M. H. (2023) · Health Expectations · doi:10.1111/hex.13707 · Cited by 10

Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study

Bolo, S. E., Kenfack, B., Wisniak, A., Happi, G. W. T., Yakam, V. F., Datchoua, A. M., Sormani, J., Stoll, B., Vassilakos, P., & Petignat, P. (2024) · BMC Women s Health · doi:10.1186/s12905-024-02917-3 · Cited by 10

Development and pilot implementation of a novel protocol to assess capacity and readiness of health systems to adopt HPV detection-based cervical cancer screening in Europe

Mensah, K., Mosquera, I., Tisler, A., Uusküla, A., Machado, J. F., Lunet, N., Nicula, F., Tăut, D., Băban, A., Basu, P. S., et al. (2024) · Health Research Policy and Systems · doi:10.1186/s12961-024-01190-y · Cited by 10

Application of Machine Learning Algorithms for Risk Stratification and Efficacy Evaluation in Cervical Cancer Screening among the ASCUS/LSIL Population: Evidence from the Korean HPV Cohort Study

Song, H., Lee, H. Y., Oh, S. A., Seong, J., Hur, S. Y., & Choi, Y. J. (2024) · Cancer Research and Treatment · doi:10.4143/crt.2024.465 · Cited by 11

Analysis of factors affecting the accuracy of colposcopic diagnosis of cervical lesions: a retrospective cohort study

Chu, Y., Chen, Q., Liu, R., Zhou, X., Bao, M., Wang, H., & Lin, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1462079 · Cited by 10

Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes: Report From an IARC Expert Consultation

Ramírez, A. T., Clifford, G. M., Dillner, J., Kuhn, L., Arbyn, M., Bhatla, N., Wentzensen, N., Sasieni, P. D., Abraham, P., Rol, M. L., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70310 · Cited by 10

The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection

Su, H., Jin, X., Kong, L., You, Y., Wu, H., Liou, Y., & Li, L. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03005-5 · Cited by 10

Lineages and sublineages of high-risk human papillomavirus types associated with cervical cancer and precancer: a systematic review and meta-analysis

van den Borst, E., Bell, M., de Beeck, K. O., Camp, G. V., Keer, S. V., & Vorsters, A. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf118 · Cited by 10

Correlation of HPV Status with Colposcopy and Cervical Biopsy Results Among Non-Vaccinated Women: Findings from a Tertiary Care Hospital in Kazakhstan

Ukybassova, T., Aimagambetova, G. N., Kongrtay, K., Kassymbek, K., Terzić, M., Makhambetova, S., Galym, M., & Kamzayeva, N. (2025) · Vaccines · doi:10.3390/vaccines13111151 · Cited by 10

The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study

Naber, S. K., de Kok, I. M. C. M., Matthijsse, S. M., & van Ballegooijen, M. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0732-7 · Cited by 10

Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening

Pimple, S. A., Mishra, G. A., & Deodhar, K. (2020) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.20.04511-6 · Cited by 10

Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Screening in Gynecological Practices in Germany

Gremke, N., Griewing, S., Felgentreff, M., Kostev, K., & Kalder, M. (2022) · Cancers · doi:10.3390/cancers14194820 · Cited by 10

Self-sampling HPV DNA test for cervical cancer screening in Singapore: A prospective study

Lim, L. M., Chan, M. F. G., Win, P. P. T., Shen, L., Ilancheran, A., Ng, J. S. Y., & Low, J. H. J. (2022) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2022133 · Cited by 10

New insights on the interaction between m6A modification and non-coding RNA in cervical squamous cell carcinoma

Shen, G., Li, F., Wang, Y., Huang, Y., Aizezi, G., Yuan, J., Ma, C., & Chen, L. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-02907-z · Cited by 10

Papel del virus del papiloma humano en el desarrollo del cáncer del cuello uterino.

Núñez-Troconis, J. (2023) · Investigación Clínica · doi:10.54817/ic.v64n2a09 · Cited by 10

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624